Moreover, ROC curve analysis was performed with the relative expression of m6A writers, IGF2BP2, and CTNNB1, and the associated area under the ROC curve (AUC), as well as the sensitivity and specificity being used to evaluate the diagnostic potency in CCA. The gene discussed is IGF2BP2; the disease is cholangiocarcinoma.